Mineralys Therapeutics (NASDAQ: MLYS) insider sale notice — 6,348 shares
Rhea-AI Filing Summary
Mineralys Therapeutics submitted a Form 144 reporting a proposed sale of 6,348 shares of common stock on 05/12/2026, tied to a broker-assisted cashless exercise of employee stock options. The filing lists a sequence of prior dispositions by David Rodman across February–May 2026, shown as individual sales (examples include 14,058 and 6,348 share lots).
Positive
- None.
Negative
- None.
Insights
Form 144 records an insider notice of intent to sell shares after option exercise.
The filing documents a proposed sale of 6,348 shares on 05/12/2026 via a broker-assisted cashless exercise. Form 144 is a notice required for resale by affiliates when certain conditions apply.
Timing and execution details are not specified beyond the exercise method; subsequent transaction confirmations will appear in broker reports or Form 4 filings if sales occur.